Evidence map›Paper›PMID 39663171›Full record

ArticleBMJ open2024

Text message intervention delivered from Australian general practices to improve breast cancer survivors' physical activity and cardiovascular risk factors: protocol for the EMPOWER-SMS-GP effectiveness implementation randomised controlled trial.

Anna C Singleton, Stephanie R Partridge, Karice K Hyun, Christine Mitchell, Rebecca Raeside, Nashid Hafiz, Brooke Nickel, David Mizrahi, Allyson Ruth Todd, Jennifer McIntosh and 5 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna C SingletonThe Daffodil Centre, a joint venture between the University of Sydney and Cancer Council New South Wales, The University of Sydney, Sydney, New South Wales, Australia anna.singleton@sydney.edu.au.ORCID http://orcid.org/0000-0002-7071-0118
Stephanie R PartridgeSusan Wakil School of Nursing and Midwifery, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-5390-3922
Karice K HyunANZAC Research Institute, Concord Repatriation General Hospital, Concord, New South Wales, Australia.ORCID http://orcid.org/0000-0002-0164-7725
Christine MitchellConsumer Representative Group, Breast Cancer Network Australia, Camberwell, Victoria, Australia.
Rebecca RaesideSusan Wakil School of Nursing and Midwifery, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-2016-6393
Nashid HafizSchool of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-5444-1624
Brooke NickelSydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-8100-4278
David MizrahiThe Daffodil Centre, a joint venture between the University of Sydney and Cancer Council New South Wales, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0003-1174-2248
Allyson Ruth ToddSusan Wakil School of Nursing and Midwifery, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-6948-9754
Jennifer McIntoshMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-6655-0940
Raymond J ChanCaring Futures Institute, Flinders University, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0003-0248-7046
Kirsty E StuartWestmead Breast Cancer Institute, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0001-5550-0377
Carolyn EeCaring Futures Institute, Flinders University, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-3363-9199
Elisabeth ElderWestmead Breast Cancer Institute, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-6686-9898
Julie RedfernInstitute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia.ORCID http://orcid.org/0000-0001-8707-5563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAustralian breast cancer survivors are at increased risk of cardiovascular disease and mortality, partly due to behavioural risk factors, including unhealthy diet and physical inactivity. Guidelines recommend health promotion delivered by general practitioners (GPs), but resources (ie, time and funding) are limited. Text message interventions sent from general practice to survivors may offer a low-resource solution but have not been evaluated. This randomised controlled trial (RCT) aims to evaluate the effectiveness and implementation of a text message intervention called EMPOWER-SMS-GP in Australian general practices. METHODS AND ANALYSIS: Multi-centre single-blind hybrid I RCT (n=678; 1:1 allocation) comparing EMPOWER-SMS-GP (n=339) to usual care (n=339) at 6 months (postintervention), 12, 18 and 24 months (maintenance) and parallel mixed-methods process evaluation using the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. INCLUSION: adults (≥18 years old) with early-stage breast cancer, completed active treatment ≤3 years ago, have a mobile phone and attended ≥1 GP appointment within 24 months. PRIMARY OUTCOME: between-group difference in mean physical activity (metabolic equivalent minutes/day) at 6 months, measured using an accelerometer. Secondary outcomes include self-reported physical activity, diet, quality of life, financial or psychological distress, fear of cancer recurrence, endocrine therapy adherence and body mass index. Statistical analyses (intention-to-treat) will include t-test (primary outcome) and linear and logistic mixed-effects regression models. ETHICS AND DISSEMINATION: Approval received from the University of Sydney Human Research Ethics Committee (Number 2023/081). Trial results will be disseminated in peer-reviewed publications, presentations, lay summaries, videos and audio for scientific, government and public audiences. TRIAL REGISTRATION NUMBER: Australia and New Zealand Clinical Trial Registry (ACTRN12624000591550, 09/05/2024; U1111-1307-3454).

Indexed as

Breast NeoplasmsCancer SurvivorsExerciseText MessagingAustraliaCardiovascular DiseasesFemaleGeneral PracticeHealth PromotionHeart Disease Risk FactorsHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicSingle-Blind MethodCell PhoneHealth ServicesImplementation ScienceONCOLOGYPrimary CarePUBLIC HEALTH

Identifiers

PMID39663171
PMCPMC11647304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.